X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MNC Pharma Stocks 

Here are the latest stock price details of India's top MNC Pharma stocks. For more detailed updates, read our MNC Pharma sector report and check the latest MNC Pharma sector results.

» Result Scoreboard | Best Performing Stocks | Refresh
SCRIP BSE PRICE (Rs) NSE PRICE (Rs) CHART GET MORE INFO
ABBOTT INDIA 4,674.45 -2.56% 4,683.95 -2.67%
 More Info 
FULFORD INDIA 2,362.00 0.04% Not Listed
 More Info 
GSK PHARMA 2,754.35 -0.06% 2,749.55 -0.42%
 More Info 
MERCK LTD 1,045.40 0.51% 1,040.20 -0.30%
 More Info 
NIFTY 50 Not Listed 9,108.00 0.24%
 More Info 
NOVARTIS 672.05 1.17% Not Listed
 More Info 
PFIZER 1,762.45 0.61% 1,759.00 0.43%
 More Info 
S&P BSE SENSEX 29,421.40 0.30% Not Listed
 More Info 
SANOFI INDIA 4,651.00 0.97% 4,626.55 0.07%
 More Info 

BSE prices: March 24, 2017  (Close)    NSE prices: March 24, 2017  (Close)



Today's Market

Global Financial Markets Remain Cautious(RoundUp)

Most of the global financial markets ended the week on a negative note. Major global markets were cautious over the week over concerns of the Trump administration's ability to push out reforms.

Related Views on News

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

More Views on News

Most Popular

Bluechips Have 60% Chance Of Losing Money At Current Levels. But a Small Group Won't...(The 5 Minute Wrapup)

Mar 17, 2017

The trend that makes a select group of bluechip stocks inherently safer even at peak index valuations.

As Digital Transactions Fall, Indians Are Going Back to Cash(Vivek Kaul's Diary)

Mar 16, 2017

Digital transactions have fallen since December 2016 both in value and volume terms.

Doubled Your Money In D-Mart? Read This Before It's Too Late(Daily Profit Hunter)

Mar 22, 2017

Apurva breaks down the historic performance of initial public offerings in the context of D-Mart.

Stock Markets and Gold Rally, Dollar Tumbles(Chart Of The Day)

Mar 16, 2017

Markets are moving up even after the fed interest rate hike.

Why Mutual Fund Investors Should Not Worry About Market High. But...(Outside View)

Mar 22, 2017

PersonalFN provides a prudent investment strategy to invest in mutual funds as market scales a new high.

More

S&P BSE HEALTHCARE


Mar 24, 2017 (Close)

COMPARE COMPANY

MARKET STATS